金城醫藥(300233.SZ):“200 噸/年煙鹼產業化項目”計劃於2021年9月底完工
格隆匯7月15日丨金城醫藥(300233.SZ)發佈股票交易異常波動公吿稱,經公司瞭解,公司全資子公司山東金城醫藥化工有限公司(“金城醫化”)在建項目“200 噸/年煙鹼產業化項目”受到市場部分投資者的關注。該項目產品主要可應用於醫藥、化工、農藥和電子煙等領域。目前公司該項目處於建設階段,根據金城醫化生產計劃及建設進度,該項目計劃於2021年9月底完工。
在此提醒廣大投資者,該項目目前處於建設階段,尚未投產運行。該項目建設完成後尚需進行試生產、竣工驗收以及辦理相關生產許可手續。未來在市場銷售方面可能存在國內外市場需求及監管政策變動的風險,存在一定的不確定因素。敬請廣大投資者理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.